blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0381142

EP0381142 - Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  18.11.1995
Database last updated on 12.07.2024
Most recent event   Tooltip18.11.1995Refusal of applicationpublished on 10.01.1996 [1996/02]
Applicant(s)For all designated states
MERRELL DOW PHARMACEUTICALS INC.
P.O. Box 156300 2110 East Galbraith Road Cincinnati
Ohio 45215-6300 / US
[N/P]
Former [1990/32]For all designated states
MERRELL DOW PHARMACEUTICALS INC.
P.O. Box 156300 2110 East Galbraith Road
Cincinnati Ohio 45215-6300 / US
Inventor(s)01 / Parker, Roger A.
480 Meadowcrest Road
Cincinnati, Ohio 45231 / US
02 / Ku, George
7972 Plantation Drive
West Chester, Ohio 45069 / US
[1990/32]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [1990/32]VOSSIUS & PARTNER
Postfach 86 07 67
D-81634 München / DE
Application number, filing date90101810.130.01.1990
[1990/32]
Priority number, dateUS1989030414231.01.1989         Original published format: US 304142
[1990/32]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0381142
Date:08.08.1990
Language:EN
[1990/32]
Type: A3 Search report 
No.:EP0381142
Date:18.03.1992
Language:EN
[1992/12]
Search report(s)(Supplementary) European search report - dispatched on:EP27.01.1992
ClassificationIPC:A61K31/40, C07D405/06, C07D409/06, C07D207/34
[1990/32]
CPC:
A61K31/40 (EP); A61P3/08 (EP); A61P3/10 (EP);
A61P9/10 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1990/32]
TitleGerman:Methode zur Verwendung von Aryl- oder Heteroaryl-1-alkyl-pyrrol-2-carbonsäure-Derivaten in der Behandlung von Krankheiten in Verbindung mit Interleukin-1[1990/32]
English:Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions[1990/32]
French:Méthode pour l'utilisation de dérivés d'acides aryl- ou hétéroaryl-1-alkyl-pyrrole-2-carboxyliques dans le traitement de maladies en relation avec l'interleukine-1[1990/32]
File destroyed:03.03.2001
Examination procedure28.12.1990Examination requested  [1991/10]
25.04.1994Despatch of a communication from the examining division (Time limit: M04)
05.09.1994Reply to a communication from the examining division
02.03.1995Despatch of communication of intention to grant (Approval: )
14.08.1995Despatch of communication that the application is refused, reason: formalities examination [1996/02]
24.08.1995Application refused, date of legal effect [1996/02]
Fees paidRenewal fee
14.12.1991Renewal fee patent year 03
07.12.1992Renewal fee patent year 04
06.12.1993Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.01.199506   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:SearchJP54128567  [ ];
 [A]EP0021207  (CIBA GEIGY AG [CH])
    [ ] - PATENSTS ABSTRACTS OF JAPAN, vol. 3, no. 152, (C-67), 14th December 1979, page 50c67; & JP-A-54 128 567 (TEIJIN K.K.) 10-05-1979, & JP54128567 A 00000000
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.